@article{JTD19258,
author = {Rolando M. D’Angelillo and Sara Ramella},
title = {Pacific trial: a new ocean or an abnormal wave?},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {3},
year = {2018},
keywords = {},
abstract = {Recently, Antonia et al. (1) have published a phase III randomized trial exploring durvalumab after concurrent chemoradiotherapy (CRT) in stage III non-small cell lung cancer (NSCLC).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/19258}
}